The behavioral results indicated that sgp130 significantly alleviated the anxiety‐ and depression‐like behaviors (Figure S6B–D, Supporting Information) and improved the atrophy of astrocytes induced by CSDS (Figure S6E, Supporting Information). Here, IL6ST is linked to major depressive disorder.